GlassScriptPhysician profile
Lawrence M Hwang
NPI 1285894949
$7,334.92
in general payments reported to CMS, 2019-2025
62 companies · $1,198 in 2025
The $1,198 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $962 · 2020: $846 · 2021: $738 · 2022: $997 · 2023: $1,239 · 2024: $1,355 · 2025: $1,198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,697 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,697.20 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,638.26 | 2019-2025 | |
| Amgen INC. | $846.01 | 2019-2025 | Evenity, Prolia, Repatha |
| Astellas Pharma US INC | $387.29 | 2019-2025 | Veozah |
| Allergan, INC. | $365.42 | 2019-2020 | |
| Abbott Laboratories | $360.15 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Pfizer INC. | $330.62 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $302.55 | 2019-2025 | |
| Glaxosmithkline, LLC. | $245.27 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Otsuka America Pharmaceutical, INC. | $195.11 | 2022-2025 | Rexulti |
| Lilly USA, LLC | $175.67 | 2020-2024 | Jardiance, Zepbound, Emgality |
| Janssen Pharmaceuticals, INC | $173.08 | 2019-2022 | |
| Radius Health, INC. | $161.82 | 2019-2025 | Tymlos |
| Stryker Corporation | $149.90 | 2019 | |
| Merck Sharp & Dohme LLC | $131.62 | 2020-2024 | Gardasil 9, Vaxneuvance, Gardasil |
| Sumitomo Pharma America, INC. | $115.55 | 2025 | Gemtesa |
Show all 62 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Hwang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.